News | December 18, 2023
Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries
10+ emerging markets, Japan & ANZ transition in final phase
10+ emerging markets, Japan & ANZ transition in final phase
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Lokavant provides clinical trial intelligence
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Propranolol LA is a generic equivalent of Inderal LA
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Subscribe To Our Newsletter & Stay Updated
